Početna › Rak prostate › Oregon
Kliničke studije za Rak prostate u državi Oregon
38 studija za Rak prostate traži sudionike na lokacijama u državi Oregon.
Gradovi u državi Oregon
Službeni tekst studije (engleski)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Oregon Health & Science University (OHSU), Portland
U tijeku regrutacijaFaza 1/2
Od 12 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT04585750Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 2. lis 2026. · NCT07200830Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Saint Alphonsus Cancer Care Center-Baker City, Baker City
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- i još 7
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06632977Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- i još 1
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT03866382Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
- Oregon Health & Science University, Portland
U tijeku regrutacijaFaza 4
Od 18 godina i više · Muškarci · Ažurirano 29. ruj 2026. · NCT07569926A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Oregon Health And Science University, Portland
U tijeku regrutacijaFaza 1
Od 18 godina i više · Muškarci · Ažurirano 28. ruj 2026. · NCT06095089Precision-Based Genomics in Prostate Cancer
- Oregon Health Sciences University, Portland
U tijeku regrutacijaOpažajna studija
Od 18 do 120 godina · Muškarci · Ažurirano 28. ruj 2026. · NCT04706663A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
- Providence Portland Medical Center, Portland
U tijeku regrutacijaFaza 1
Od 18 godina i više · Muškarci · Ažurirano 24. ruj 2026. · NCT07543055Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Oregon Urology Institute, Springfield
U tijeku regrutacijaFaza 2/3
Od 18 do 100 godina · Muškarci · Ažurirano 22. ruj 2026. · NCT06780670A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Oregon Oncology Specialists, Salem
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 22. ruj 2026. · NCT07213674A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Springfield
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 18. ruj 2026. · NCT06952803High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- VA Portland Health Care System, Portland, OR, Portland
U tijeku regrutacijaFaza 2
Od 18 godina i više · Muškarci · Ažurirano 17. ruj 2026. · NCT05011383Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- VA Portland Health Care System, Portland, OR, Portland
U tijeku regrutacijaFaza 2
Od 18 godina i više · Muškarci · Ažurirano 17. ruj 2026. · NCT04038502A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- VA Portland Health Care System ( Site 0038), Portland
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 17. ruj 2026. · NCT06925737Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Oregon Urology, Springfield
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 11. ruj 2026. · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- Providence Portland Medical Center, Portland
- i još 2
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 10. ruj 2026. · NCT05946213MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
- Oregon Health & Science University, Portland
U tijeku regrutacija
Od 18 godina i više · Muškarci · Ažurirano 1. ruj 2026. · NCT05710380A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
- Oregon Health & Science University, Portland
U tijeku regrutacijaFaza 2
Od 18 godina i više · Muškarci · Ažurirano 31. kol 2026. · NCT05726292Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
- Research Site, Portland
U tijeku regrutacijaFaza 1/2
Od 18 do 99 godina · Muškarci · Ažurirano 27. kol 2026. · NCT07590934AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Portland
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 26. kol 2026. · NCT07611110A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
- VA Portland Health Care System, Portland, OR, Portland
U tijeku regrutacijaFaza 2
Od 18 godina i više · Muškarci · Ažurirano 25. kol 2026. · NCT05593497Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- Bay Area Hospital, Coos Bay
- i još 5
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 19. kol 2026. · NCT04423211FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Oregon Health and Science University, Portland
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 17. kol 2026. · NCT05919264Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- Bay Area Hospital, Coos Bay
- i još 8
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 14. srp 2026. · NCT06592924A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
- Oregon Health & Science University, Portland
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Muškarci · Ažurirano 25. lip 2026. · NCT06457919Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
- VA Portland Health Care System, Portland
U tijeku regrutacijaFaza 2
Od 18 godina i više · Muškarci · Ažurirano 15. lip 2026. · NCT05422911International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- Oregon Health & Science University Hospital, Portland
U tijeku regrutacijaOpažajna studija
Od 21 godina i više · Muškarci · Ažurirano 22. svi 2026. · NCT03151629Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
- OHSU Knight Cancer Institute, Portland
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 godina i više · Muškarci · Ažurirano 15. svi 2026. · NCT04472338A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Research Site, Portland
U tijeku regrutacijaFaza 1
Od 18 godina i više · Muškarci · Ažurirano 12. svi 2026. · NCT06879041Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
- OHSU Knight Cancer Institute, Portland
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 8. svi 2026. · NCT06011499GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer
- OHSU Knight Cancer Institute, Portland
U tijeku regrutacija
Od 65 godina i više · Muškarci · Ažurirano 6. svi 2026. · NCT07504835Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
- Saint Alphonsus Medical Center-Baker City, Baker City
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- i još 9
U tijeku regrutacijaFaza 2
Od 18 godina i više · Muškarci · Ažurirano 29. sij 2026. · NCT05806515Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- Saint Alphonsus Cancer Care Center-Baker City, Baker City
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 22. sij 2026. · NCT06470243cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Oregon Health Sciences University, Portland
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 godina i više · Oba spola · Ažurirano 20. sij 2026. · NCT05366881SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Portland
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774EMBRACE: Exercising Together
- OHSU Knight Cancer Institute, Portland
U tijeku regrutacijaFaza 2Zdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 29. svi 2025. · NCT06049355Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
- VA Portland Healthcare System, Portland
U tijeku regrutacijaFaza 2
Od 18 godina i više · Muškarci · Ažurirano 20. tra 2022. · NCT03753243Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.